Navigation Links
New Research Finds Recession Has Greater Impact on Health of Parents than Children with Specific Findings on Hispanics
Date:5/18/2009

Most Hispanics agree that the health of the entire family is important, yet parents prioritize children's health over their own

RIDGEFIELD, Conn., May 18 /PRNewswire/ -- The economic downturn is contributing to a decline in overall family health in the Hispanic community, with parents prioritizing their children's health over their own. While 44 percent of Hispanics consider it equally important for parents to take care of their own health and the health of their children, significantly more parents say the economic downturn has affected their own health and wellness compared to that of their children (69 percent vs. 59 percent).

In fact, Hispanic parents are making their healthcare a lower priority overall, ranking their own healthcare fourth (five percent) on a list of top priorities -- below their children's healthcare (61 percent), housing (20 percent) and even food and groceries (7 percent). In addition, Hispanic parents are worried about their family's overall healthcare situation. Forty-five percent of Hispanics are concerned about their ability to afford healthcare, medicines and treatment for themselves or their families. And their perspective on the future is even gloomier, with 81 percent of Hispanic parents indicating they expect the current economic downturn to affect their own health or that of a family member.

The survey of 2,186 American adults was commissioned by Boehringer Ingelheim to evaluate Americans' views and concerns about healthcare access and included 328 Hispanics.

"As a family company, Boehringer Ingelheim is committed to improving the health of patients and their families, and these survey findings underscore the importance of expanding healthcare options for every generation," said J. Martin Carroll, president and CEO, Boehringer Ingelheim. "We are committed at all levels to partnering with community organizations to improve health and wellness for those most in need, through supporting free clinics -- like the new Boehringer Ingelheim AmeriCares Free Clinic -- access to medicines, and more."

In addition, only 30 percent of Hispanics say they have health insurance that generally meets their needs and is reasonably affordable given their current financial situation. These findings offer further perspective on recent reports from the National Association of Community Health Centers which found that 60 million people in the United States lack access to basic medical care.

Other findings from the survey include:

  • When it comes to healthcare in the current economic downturn, an unforeseen medical or personal crisis is a concern for 38 percent of Hispanics, followed by concerns about their ability to afford health insurance (37 percent).
  • Fourteen percent of Hispanics reported not receiving healthcare because of a lack of health insurance, inability to pay, or other reasons; another 15 percent said they do the best they can to pay for healthcare themselves because they do not have health insurance or government support.
  • Three out of four (74 percent) Hispanics would seek out and go to a free clinic on a regular basis to meet their and their family's healthcare needs if they lost or could not afford health insurance, had no health insurance or could not qualify for a government-sponsored healthcare program.
  • However, half (49 percent) of Hispanics report not knowing how to find out about free clinics, what services are available and if their families qualify.

About the Boehringer Ingelheim Family Health Survey

The Boehringer Ingelheim Family Health Survey was conducted on behalf of Boehringer Ingelheim by Greenfield Online between April 28 and April 30, 2009. The online survey interviewed a national sample 2,186 US adults age 18 and older. The results are weighted and balanced to conform to US census parameters for gender, age, region of residence, ethnicity and other demographics. The survey has a plus or minus 2-3 percent margin of error at 95 percent confidence.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and approximately 41,300 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit http://us.boehringer-ingelheim.com.


'/>"/>
SOURCE Boehringer Ingelheim
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. New research shows how chronic stress worsens neurodegenerative disease course
6. New research explores newborn in-hospital weight loss
7. Research may unlock mystery of autisms origin in the brain
8. Bipolar disorder relapses halved by Melbourne researchers
9. HIVs impact in Zimbabwe explored in new research
10. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
11. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... A new ... with severe congenital diaphragmatic hernia have better survival rates if surgery is performed ... (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs into ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... won the $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan ... the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ ...
(Date:4/29/2016)... NY (PRWEB) , ... April 29, 2016 , ... ... and engineer of patented products, announces the Gyrociser, an exercise invention which aids ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about ... of skin cancer deaths. More than 10,000 people are expected to die of melanoma this ... it is the one of the most commonly diagnosed cancers in young women. A recent ...
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
(Date:4/27/2016)... , April 27, 2016 ... Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor ... announced its sales for the first quarter ended March ... and the execution of its commercial strategy. ...
Breaking Medicine Technology: